Mao Hagihara - Concepedia

Author

Mao Hagihara

Aichi Medical University Hospital ORCID

Also Known As

Hagihara M, Hagihara,Mao, M Hagihara, M. Hagihara, Mao Hagihara

198

Publications

3.2K

Citations

H-Index

126

Concepts

All Affiliations

Aichi Medical University Hospital Aichi Medical University Hartford Financial Services (United States)Hartford Hospital Kinjo Gakuin University

About

Mao Hagihara is an author at Aichi Medical University Hospital specializing in medicine, pharmacology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	45	1.6K
2	Health Sciences	11	12	473
3	Public Health	2	2	46
4	Allergy	2	2	99
5	Natural Sciences	1	1	26

Mao Hagihara

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis Mao Hagihara, Yasutoshi Kuroki, Tadashi Ariyoshi, iScience	2019	153
Midkine induces the transformation of NIH3T3 cells Kenji Kadomatsu, Mao Hagihara, Shafinaz Akhter, British Journal of Cancer Cell DivisionCell InteractionCell DeathCell ProliferationCytoskeleton	1997	148
Age-Dependent Changes in Lipid Peroxide Levels in the Lipoprotein Fractions of Human Serum Mao Hagihara, Ikuo Nishigaki, Mitsuaki Maseki, Journal of Gerontology AgingLipid PeroxidationLipid Peroxide LevelLipid Peroxide LevelsHyperlipidemia	1984	92
Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19 Daisuke Sakanashi, Nobuhiro Asai, Akiko Nakamura, Journal of Infection and Chemotherapy Diagnostic VirologyMolecular Diagnostic TechniquesViral DiagnosticsCovid-19 PandemicPathology	2020	85
Efficacy and accuracy of qSOFA and SOFA scores as prognostic tools for community-acquired and healthcare-associated pneumonia Nobuhiro Asai, Hiroki Watanabe, Arufumi Shiota, International Journal of Infectious Diseases	2019	75
Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae Hazuki Nakai, Mao Hagihara, Hideo Kato, Journal of Infection and Chemotherapy Antimicrobial SusceptibilityMicrobial DiseaseAntibioticsMedicineExtended-spectrum β-Lactamase	2016	74
<i>In Vitro</i> Pharmacodynamics of Polymyxin B and Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii Mao Hagihara, Seth T. Housman, David P. Nicolau, Antimicrobial Agents and Chemotherapy Antimicrobial ChemotherapyAntibiotic ResistanceBacterial PathogensDrug ResistanceActive Antibiotics	2013	68
<i>In Vitro</i> Pharmacodynamics of Vancomycin and Cefazolin Alone and in Combination against Methicillin-Resistant Staphylococcus aureus Mao Hagihara, Dora E. Wiskirchen, Joseph L. Kuti, Antimicrobial Agents and Chemotherapy Antimicrobial ChemotherapyDrug ResistanceAntimicrobial StewardshipMrsa IsolatesAntimicrobial Therapy	2011	61
Clostridium butyricum enhances colonization resistance against Clostridioides difficile by metabolic and immune modulation Mao Hagihara, Tadashi Ariyoshi, Yasutoshi Kuroki, Scientific Reports	2021	58
The impact of Clostridium butyricum MIYAIRI 588 on the murine gut microbiome and colonic tissue Mao Hagihara, Rieko Yamashita, Asami Matsumoto, Anaerobe Murine Gut MicrobiomeDysbiosisGut MicrobiologyColonic TissueMicrobial Ecology	2018	57

Page 1